Generic firms set to benefit from China's health reforms
This article was originally published in Scrip
Executive Summary
It appears that local generic firms are set to benefit the most when China publishes its National Essential Drug List (NEDL) this year, a key part of the country's $124.5 billion health reform which will introduce universal coverage of basic medical insurance.